Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
TOBRAMYCIN FOR INJECTION FRESENIUS KABI CANADA LTD Actual shortage 1.2G Updated Report 2024-06-02 229350
HYDROMORPHONE HYDROCHLORIDE INJECTION USP PFIZER CANADA ULC Actual shortage 10MG Updated Report 2024-06-02 225629
ISDN AA PHARMA INC Actual shortage 10MG Updated Report 2024-06-02 228774
ACETAZOLAMIDE FOR INJECTION, USP STERIMAX INC Actual shortage 500MG Updated Report 2024-06-02 188809
APO-PREGABALIN APOTEX INC Actual shortage 50MG Updated Report 2024-06-02 216738
CALCITRIOL INJECTION USP STERIMAX INC Actual shortage 1MCG Updated Report 2024-06-02 218148
AA-AMILZIDE AA PHARMA INC Actual shortage 5MG 50MG Updated Report 2024-06-02 228768
XYLAC PENDOPHARM DIVISION OF PHARMASCIENCE INC Resolved 25MG Updated Report 2024-06-01 222737
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP PFIZER CANADA ULC Resolved 149MG Updated Report 2024-06-01 166363
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP PFIZER CANADA ULC Resolved 149MG Updated Report 2024-06-01 200798

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
BUPIVACAINE HYDROCHLORIDE INJECTION, USP STERIMAX INC Discontinued 7.5MG Updated Report 2024-06-01 216017
AVAPRO SANOFI-AVENTIS CANADA INC To be discontinued 75MG New Report 2024-05-31 229306
REPATHA AMGEN CANADA INC To be discontinued 120MG Updated Report 2024-05-24 223420
ZOVIRAX GLAXOSMITHKLINE INC Discontinued 200MG New Report 2024-05-24 228728
VITAMIN A ACID BAUSCH HEALTH, CANADA INC. Discontinued 0.01% Updated Report 2024-05-23 217835
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) SANDOZ CANADA INCORPORATED Discontinued 10000UNIT Updated Report 2024-05-18 228249
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED Discontinued 20MG Updated Report 2024-05-18 228256
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED Discontinued 40MG Updated Report 2024-05-18 228263
SANDOZ SENNA S SANDOZ CANADA INCORPORATED Discontinued 50MG 8.6MG Updated Report 2024-05-18 228268
SUPREFACT DEPOT 3 MONTHS CHEPLAPHARM ARZNEIMITTEL GMBH Discontinued 9.45MG Updated Report 2024-05-17 228166